Search hospitals
>
Michigan
>
Pontiac
Saint Joseph Mercy Oakland
Claim this profile
Pontiac, Michigan 48341
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Ovarian Cancer
Conducts research for Cancer
477 reported clinical trials
10 medical researchers
Summary
Saint Joseph Mercy Oakland is a medical facility located in Pontiac, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Ovarian Cancer, Cancer and other specialties. Saint Joseph Mercy Oakland is involved with conducting 477 clinical trials across 522 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Area of expertise
Breast Cancer
Saint Joseph Mercy Oakland has run 88 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Saint Joseph Mercy Oakland has run 81 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Tareq Al Baghdadi
Genesys Hurley Cancer Institute
9 years of reported clinical research
Christopher M. Reynolds, MD
Saint Joseph Mercy Hospital
3 years of reported clinical research
Philip J. Stella
Saint Joseph Mercy Hospital
5 years of reported clinical research
Elie G. Dib
Genesys Hurley Cancer Institute
7 years of reported clinical research
Clinical Trials running at Saint Joseph Mercy Oakland
Lung Cancer
Breast Cancer
Bladder Cancer
Prostate Cancer
Breast cancer
Ovarian Cancer
Esophageal cancer
Multiple Myeloma
Bladder Carcinoma
Non-Small Cell Lung Cancer
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting
2 awards
Phase 3
14 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Joseph Mercy Oakland?
Saint Joseph Mercy Oakland is a medical facility located in Pontiac, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Ovarian Cancer, Cancer and other specialties. Saint Joseph Mercy Oakland is involved with conducting 477 clinical trials across 522 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Saint Joseph Mercy Oakland located?
Saint Joseph Mercy Oakland Hospital is located at 44405 Woodward Ave, Pontiac, MI. It is approximately a 2-minute walk from the bus stop at Woodward + South Blvd.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Saint Joseph Mercy Oakland, contact a Saint Joseph's Financial Counselor at (914) 751-0372 or a St. Vincent's Financial Counselor at (914) 925-5492. For insurance inquiries, contact the billing department at 800-494-5797.
What insurance does Saint Joseph Mercy Oakland accept?
Saint Joseph Mercy Oakland Hospital accepts a variety of insurance plans, such as Aetna, BCBS/Federal/PPO/Preferred, BCN Advantage MyBlue, and BCN HMO, among others. Accepted insurances may differ by practice or office location within the Trinity Health IHA Medical Group. It's advised to confirm insurance acceptance with your specific office or practice, and verify coverage with your employer or insurance company before seeking non-emergency treatment.
What awards or recognition has Saint Joseph Mercy Oakland received?
Saint Joseph Mercy Oakland, located in Pontiac, Michigan, is a distinguished national teaching hospital, consistently ranking in the top 10 percent for patient safety, quality, and performance. It is part of St. Joseph's Health System, which received $499,999 in NIH funding in 2010.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.